Nuo Therapeutics, Inc. Research And Development Expense

• This data is from Nuo Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2022.
• XBRL data for this metric is available from 2010 to 2021 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 11 years of available data (2010 to 2021), Nuo Therapeutics, Inc.'s Research And Development Expense has declined by 100.0%.
• Historical annual values: Fiscal year 2021: $0.00 | Fiscal year 2020: $0.00 | Fiscal year 2019: $181.2 thousand | Fiscal year 2018: $576.2 thousand | Fiscal year 2017: $1.33 million | Fiscal year 2015: $2.55 million | Fiscal year 2014: $4.04 million | Fiscal year 2013: $3.80 million | Fiscal year 2012: $3.39 million | Fiscal year 2011: $98.1 thousand | Fiscal year 2010: $415.6 thousand.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026